Ro 46-2005

CAS No. 150725-87-4

Ro 46-2005( Ro-462005 )

Catalog No. M12102 CAS No. 150725-87-4

Ro 46-2005 is the first synthetic orally active nonpeptide antagonist of endothelin receptor with equipotent potency (IC50=0.2-0.5 uM) for ETA and ETB.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 58 Get Quote
10MG 110 Get Quote
25MG 200 Get Quote
50MG 335 Get Quote
100MG 479 Get Quote
200MG 692 Get Quote
500MG 1053 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Ro 46-2005
  • Note
    Research use only, not for human use.
  • Brief Description
    Ro 46-2005 is the first synthetic orally active nonpeptide antagonist of endothelin receptor with equipotent potency (IC50=0.2-0.5 uM) for ETA and ETB.
  • Description
    Ro 46-2005 is the first synthetic orally active nonpeptide antagonist of endothelin receptor with equipotent potency (IC50=0.2-0.5 uM) for ETA and ETB; has no effect on plasma concentrations of big ET-1 and only a minor effect on those of ET-3; sufficient to inhibit the pressor effect of the precursor big ET-1 at much lower doses (1 to 10 mg/kg i.v.).Hypertension Preclinical.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Ro-462005
  • Pathway
    GPCR/G Protein
  • Target
    Endothelin Receptor
  • Recptor
    ET-A|ET-B
  • Research Area
    Cardiovascular Disease
  • Indication
    Hypertension

Chemical Information

  • CAS Number
    150725-87-4
  • Formula Weight
    473.542
  • Molecular Formula
    C23H27N3O6S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: ≥ 28 mg/mL
  • SMILES
    O=S(C1=CC=C(C(C)(C)C)C=C1)(NC2=NC=NC(OCCO)=C2OC3=CC=CC(OC)=C3)=O
  • Chemical Name
    Benzenesulfonamide, 4-(1,1-dimethylethyl)-N-[6-(2-hydroxyethoxy)-5-(3-methoxyphenoxy)-4-pyrimidinyl]-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Clozel M, et al. Nature. 1993 Oct 21;365(6448):759-61. 2. Breu V, et al. FEBS Lett. 1993 Nov 15;334(2):210-4. 3. Clozel M, et al. J Cardiovasc Pharmacol. 1993;22 Suppl 8:S377-9.
molnova catalog
related products
  • Clazosentan

    Clazosentan (Ro 61-1790) is a selective antagonist of the endothelin A receptor (ETAreceptor) that inhibits ET-1-mediated vasoconstriction, preventing cerebral vasospasm and vasospasm-associated cerebral infarction.

  • Bosentan

    Bosentan is an endothelin (ET) receptor antagonist for ET-A and ET-B with Ki of 4.7 nM and 95 nM, respectively.

  • Atrial Natriuretic P...

    Atrial Natriuretic Peptide (1-28), rat is the major circulating form of ANP in rats.